Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rovi Corporation (ROVI) Tumbles, Netflix, Inc. (NFLX) Soars Following Supreme Court Ruling

Page 1 of 2

The shares of Rovi Corporation (NASDAQ:ROVI) are trading 16.48% lower after an update from the digital entertainment company cited an unfavorable Supreme Court ruling. In a court case against Netflix, Inc. (NASDAQ:NFLX) concerning five patents involved in over-the-top (OTT) video service, the court has ruled in favor of Netflix, Inc. (NASDAQ:NFLX), stating that the patents are invalid, referring to a 2014 Supreme Court ruling involving Alice Corp. Pty. Ltd. v. CLS Bank International. On the other hand, Netflix’s shares are up by 16.43% today, on both the ruling and the company’s second quarter financial results, released after-hours yesterday.

After the decision, Samir Armaly, Executive Vice President of intellectual property and licensing division of Rovi Corp, said, “While we are pleased that the Court sided with Rovi on the key claim construction issues, we are disappointed in, and strongly disagree with, the Court’s decision finding the five patents invalid and plan to appeal that decision.” He further cited other major video streaming service providers using its patents. Mr. Armaly added, “Other leading OTT providers, including Apple, Google and Hulu, have previously taken a license under the Rovi patent portfolio, and we remain confident that Netflix, Inc. (NASDAQ:NFLX) requires a similar license.”

Netflix, Inc. (NASDAQ:NFLX), Homepage, Provider, Sing, logo, magnifying glass, website

Gil C /

Earlier in March, activist investor Glenn W. Welling’s Engaged Capital filed preliminary proxy materials with the SEC after losing patience in the digital entertainment company’s efforts to increase shareholder value. The investment manager had 549,900 shares of Rovi Corporation (NASDAQ:ROVI) in its portfolio at the time, with a market value of $10.01 million as of the end of the first quarter. Prior to filing the proxy materials, Engaged Capital raised several issues that it believed could help the company create more value for its investors. The fund sent an open letter to the management of the digital entertainer nominating four directors, including Mr. Welling, while pointing out the negative shareholder value generated in the past couple of years. However, Rovi Corporation (NASDAQ:ROVI) criticized this step, while stating that the fund was undermining the selection process by not providing interview access to its nominated candidates. In May, two of those nominees were elected to the board by Rovi shareholders, those being Raghavendra Rau and Glenn W. Welling.

Glenn W. Welling
Glenn W. Welling
Engaged Capital

The shares of Rovi Corporation (NASDAQ:ROVI) are down by 34.63% year-to-date heading into its second quarter financial results on July 30. Despite the poor run for the company’s shares, smart money held a bullish outlook on the stock during the first quarter, with 32 hedge fund investors holding positions worth $171.21 million at the end of the period. These figures were far better than the previous quarter investments of $130.84 million from 20 investors. We also took into account the 19.39% decline in the shares of Rovi Corporation (NASDAQ:ROVI) during the first quarter, indicating a very positive sentiment among hedge fund investors. Some of the primary investors of the company include Israel Englander’s Millennium Management with 1.38 million shares valued at $25.4 million, Chuck Royce’s Royce & Associates, and George Soros’ Soros Fund Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!